Physiomics PLC

RVW1

Company Profile

  • Business description

    Physiomics PLC is a United Kingdom-based firm that provides consulting services to biopharmaceutical companies and research institutes in the areas of outsourced modelling and simulation (quantitative pharmacology), biometrics, and data science (bioinformatics). Its business activities involve the use of industry-standard technologies and a proprietary technology platform called Virtual Tumour. The company has three service lines: Biometrics, Modelling and Simulation (Quantitative Pharmacology) and Personalised Medicine. It derives revenue from the UK, the European Union and Switzerland.

  • Contact

    140 Eastern Avenue
    Bee House, Milton Park
    AbingdonOX14 4SB
    GBR

    E: [email protected]

    https://www.physiomics.co.uk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    10

Stocks News & Analysis

stocks

After earnings, is Microsoft a buy, a sell, or fairly valued?

With third-quarter results surpassing even high-end expectations, here’s what we think of Microsoft stock.
stocks

Albemarle earnings: Shares rally on strong profit growth well above consensus estimates

Albemarle should see sequential profit growth in the second quarter and maintain higher profits through the year.
stocks

Ahead of IPOs, AI giants keep making circular deals. Here’s why that’s a risk - Clone

With OpenAI reportedly missing revenue targets, the imbalanced risks of circular deals become clearer.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,980.5031.60-0.35%
CAC 408,202.0897.34-1.17%
DAX 4024,663.61255.08-1.02%
Dow JONES (US)49,596.97313.62-0.63%
FTSE 10010,276.95161.71-1.55%
HKSE26,367.55258.73-0.97%
NASDAQ25,806.2032.75-0.13%
Nikkei 22562,713.65120.19-0.19%
NZX 50 Index13,175.1395.48-0.72%
S&P 5007,337.1128.01-0.38%
S&P/ASX 2008,744.4036.40-0.41%
SSE Composite Index4,178.191.90-0.05%

Market Movers